Authors: Thompson, TA Pusic, A Kerrigan, CL Sargeant, R Slezak, S Chang, BW Helzlsouer, K Manson, P

Citation: Ta. Thompson et al., Surgeon perspectives on surgical options for early-stage breast cancer, PLAS R SURG, 105(3), 2000, pp. 910-918

Authors: Shen, WP Li, BQ Wetzel, MA Rogers, TJ Henderson, EE Su, SB Gong, WH Le, YY Sargeant, R Dimitrov, DS Oppenheim, JJ Wang, JM

Citation: Wp. Shen et al., Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes, BLOOD, 96(8), 2000, pp. 2787-2794

Authors: Shen, WP Li, BQ Wetzel, MA Rogers, TJ Henderson, EE Su, SB Gong, WH Le, YY Sargeant, R Dimitrov, DS Oppenheim, JJ Wang, JM

Citation: Wp. Shen et al., Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes, BLOOD, 96(8), 2000, pp. 2887-2894

Authors: Shen, WP Proost, P Li, BQ Gong, WH Le, YY Sargeant, R Murphy, PM Van Damme, J Wang, JM

Citation: Wp. Shen et al., Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines, BIOC BIOP R, 272(1), 2000, pp. 276-283

Authors: Pusic, A Thompson, TA Kerrigan, CL Sargeant, R Slezak, S Chang, BW Helzlsouer, KJ Manson, PN

Citation: A. Pusic et al., Surgical options for early-stage breast cancer: Factors associated with patient choice and postoperative quality of life, PLAS R SURG, 104(5), 1999, pp. 1325-1333

Authors: Su, SB Gong, WH Grimm, M Utsunomiya, I Sargeant, R Oppenheim, JJ Wang, JM

Citation: Sb. Su et al., Inhibition of tyrosine kinase activation blocks the down-regulation of CXCchemokine receptor 4 by HIV-1 gp120 in CD4(+) T cells, J IMMUNOL, 162(12), 1999, pp. 7128-7132